Weiwei Xiang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Subarachnoid Hemorrhage

Top Venues

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Weiwei Xiang, Kan Wang, Lu Han, Ze Wang, Zhiyang Zhou, Shuwei Bai, Jing Peng, Chong Xie, Yangtai Guan
CD22 blockade aggravates EAE and its role in microglia polarization. CNS neuroscience & therapeutics 30 (5) (2024)
Weiwei Xiang, Kan Wang, Lu Han, Ze Wang, Zhiyang Zhou, Shuwei Bai, Jing Peng, Chong Xie, Yangtai Guan
CD22 blockade aggravates EAE and its role in microglia polarization. CNS neuroscience & therapeutics 30 (5) (2024)
Weiwei Xiang, Kan Wang, Lu Han, Ze Wang, Zhiyang Zhou, Shuwei Bai, Jing Peng, Chong Xie, Yangtai Guan
CD22 blockade aggravates EAE and its role in microglia polarization. CNS neuroscience & therapeutics 30 (5) (2024)
Weiwei Xiang, Kan Wang, Lu Han, Ze Wang, Zhiyang Zhou, Shuwei Bai, Jing Peng, Chong Xie, Yangtai Guan
CD22 blockade aggravates EAE and its role in microglia polarization. CNS neuroscience & therapeutics 30 (5) (2024)
Jing Peng, Kan Wang, Weiwei Xiang, Yan Li, Yong Hao, Yang-Tai Guan
Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus. CNS neuroscience & therapeutics 25 (12) (2019)